Harbor Capital Advisors Inc. decreased its position in Envista Holdings Co. (NYSE:NVST – Free Report) by 15.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 342,351 shares of the company’s stock after selling 62,238 shares during the quarter. Harbor Capital Advisors Inc. owned 0.20% of Envista worth $6,604,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC grew its stake in Envista by 30.5% during the 4th quarter. GAMMA Investing LLC now owns 2,304 shares of the company’s stock valued at $44,000 after purchasing an additional 538 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its stake in shares of Envista by 50.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after buying an additional 728 shares during the last quarter. Victory Capital Management Inc. boosted its stake in shares of Envista by 2.3% during the 2nd quarter. Victory Capital Management Inc. now owns 36,021 shares of the company’s stock valued at $599,000 after buying an additional 800 shares during the last quarter. Blue Trust Inc. grew its position in shares of Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after buying an additional 804 shares in the last quarter. Finally, Huntington National Bank increased its stake in shares of Envista by 97.8% in the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock worth $38,000 after buying an additional 949 shares during the last quarter.
Envista Stock Down 3.0 %
Envista stock opened at $18.60 on Friday. The firm has a market capitalization of $3.20 billion, a P/E ratio of -2.39, a P/E/G ratio of 2.71 and a beta of 1.33. The company has a 50-day simple moving average of $20.19 and a 200-day simple moving average of $18.58. Envista Holdings Co. has a one year low of $15.15 and a one year high of $25.45. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.08.
Analyst Ratings Changes
NVST has been the topic of a number of research analyst reports. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and increased their price objective for the company from $16.00 to $23.00 in a research note on Thursday, October 31st. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research note on Thursday, October 31st. Evercore ISI upped their price objective on Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Stifel Nicolaus lifted their target price on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, Mizuho began coverage on Envista in a research report on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price target on the stock. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Envista currently has a consensus rating of “Hold” and an average target price of $20.21.
Check Out Our Latest Stock Report on NVST
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
See Also
- Five stocks we like better than Envista
- The 3 Best Blue-Chip Stocks to Buy Now
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Choose Top Rated Stocks
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.